Columbus Circle Investors’s Integra LifeSciences IART Stock Holding History

Columbus Circle Investors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-395,457	Closed	-$21.6M	–	298
2017 Q2	$21.6M	Sell	395,457 -52,555	-12%	-$2.51M	0.36%	82
2017 Q1	$18.9M	Buy	+448,012	New	+$19.1M	0.27%	98
2016 Q4	–	Sell	-622,020	Closed	-$25.7M	–	274
2016 Q3	$25.7M	Sell	622,020 -168,670	-21%	-$7.07M	0.28%	83
2016 Q2	$31.5M	Buy	+790,690	New	+$28.4M	0.32%	93

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Columbus Circle Investors's IART Position: Q3 2017 in Review

Columbus Circle Investors sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 395,457 shares — an estimated $21.6M sold.

Columbus Circle Investors first reported a position in IART in Q2 2016 and held it in 4 quarters. The position peaked at $31.5M in Q2 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

Columbus Circle Investors reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
Columbus Circle Investors sold 395,457 Integra LifeSciences shares in Q3 2017, an estimated $21.6M.
Columbus Circle Investors first reported a position in Integra LifeSciences in Q2 2016 and held it in 4 quarters.
Columbus Circle Investors's Integra LifeSciences position peaked at $31.5M in Q2 2016.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Columbus Circle Investors's 13F filing for Q3 2017, filed 8 Nov 2017.